0000134758 00000 n endobj 0000001949 00000 n 7-h��y���%��9��4cӀ4+�x�fd`l R��m�`.�@� ��=� 1 0 obj However, the mean AUC of epirubicinol and 7-deoxy-aglycone increased by … Possible side effects 5. You may need to read it again. Pfizer RxPathways connects eligible patients to a range of assistance programs to help them access their Pfizer prescriptions. These highlights do not include all the information needed to use HALAVEN safely and effectively. Effect of Docetaxel. Need help paying for Pfizer medicines? ;~�箧����3��x�����f:�~4���Ov���g�� endobj Epirubicin Hydrochloride Injection, USP is available in single-use vials containing 2 mg epirubicin hydrochloride, USP per mL as a sterile, preservative-free, ready-to-use solution in the … <> ��[�Q7I1O��������fCC��s����j��Z�J�&����DV����3�9� 0 489 0 obj <>/Filter/FlateDecode/ID[<566CB3A3AB1E93418C55D214C9F46423><8E68214E97F89B4B806FB322D4DEAC84>]/Index[480 32]/Info 479 0 R/Length 62/Prev 100472/Root 481 0 R/Size 512/Type/XRef/W[1 2 1]>>stream PACKAGE INSERT TEMPLATE FOR EPIRUBICIN HYDROCHLORIDE INTRAVESICAL INJECTION & INTRAVENOUS INFUSION Brand or Product Name [Product name] …mg/ml Injection [Product name] …mg/ml Vials Name and Strength of Active Substance(s) Epirubicin hydrochloride ….mg/ml [Example of strengths: 10mg/5ml , 50mg/25ml, 200mg/100ml, 20mg/10ml] Do not freeze. 480 0 obj <> endobj Epirubicin is used …

Keep this leaflet. 0000002574 00000 n Patient Assistance Programs.

0000007457 00000 n 0000121900 00000 n kD);�@��]Ͽ8�w瞫D��#�@�7�@bv��Y�(�\n�ٶPQ������w�R��#��[��nX��Z����+��W�>��Y߻2R�(�?e�*���p�.���+&�h���K��;� y������;e��z޻Ӌ3��*�V�G��4��9����?O�θ�ώ��HF�sq�����kx���@ͅ�wq�i&���������C�Qi�m'�Е�v��gv;gWp���3wN�c���8;��X����W'�� i�#j�����E~l�S��W`��a�SL)7�H�������q������$ ������>�/.������=��M�"���[����؁��s�I��x�Tp��@�.��J|��U�SIO��c6��>A�gG���2K(���mTbi���'1P5�/�r���/7�H��L(��i�ߨCN\@"S&�C�8~���C���w�����y�:y�G.��WG>�7�\�z\�0p���]̄t����:H���,ln�#���(\MQxѩ����+�O�w*�w��>g �9�m b�֓� �4�qJ�A�,�I?�-RBa_��oD�&JȊ֗٪.J�w��R����,[�=� �*P6ȿꈡ�0z]�:8�HV� �wv�NӍ��qD� �h[[�݌�F���[��l�4�8C�N:.�.�S�vk��{�Q)>�0�{��ڒ�'A��3�c{n�w�������yVV��bs8��&�z��i=�FQ$ɿI`;�w�9���� See full prescribing information for 0000009924 00000 n Version: pfpadrii10612 Supersedes: pfpadrii10909 1 of 18 PRODUCT INFORMATION ADRIAMYCIN® Solution for Injection WARNINGS 1. 0000006684 00000 n 0000004262 00000 n Severe local tissue … Version: pfpadrii10612 Supersedes: pfpadrii10909 1 of 18 PRODUCT INFORMATION ADRIAMYCIN® Solution for Injection WARNINGS 1. Further information 1. 207 38 WARNINGS 1. [���2T�#�%�����8/��j endobj 0000120901 00000 n 511 0 obj <>stream

endstream endobj 481 0 obj <>/Metadata 45 0 R/PageLayout/OneColumn/Pages 475 0 R/StructTreeRoot 56 0 R/Type/Catalog>> endobj 482 0 obj <>/ExtGState<>/Font<>/XObject<>>>/Rotate 0/StructParents 0/Type/Page>> endobj 483 0 obj <>stream <>>> 0000005949 00000 n 0000000016 00000 n �0�nLI��6����Y{E��ܢ-�PV�-P�z�[����d�!�����o��)Ig�j���ˉ�YV������E6O�ۜ�/t��6F˞�*�E�u� ����:��l��QV�1����&�d+���#S����ؘ9T�~G�,�en�PV�� stream 0000091171 00000 n b�ύ��S?�4YA|�p��9�/��t�;�����!䋬Xe��C�)��K�fdz� E�Y��-�@�����mRR>����u&&a)�f5��fF˂�QK����z͊�v�3� .O��q%�U�#�Rjʯ�~M��w�����V���A���HH�T4��i %PDF-1.5 %���� This gelled product will return to a slightly viscous to mobile solution after 2 to a maximum of 4 hours equilibration at controlled room temperature (15-25°C). Doxorubicin Hydrochloride Injection/for Injection is an anthracycline topoisomerase inhibitor indicated: as a component of multiagent adjuvant chemotherapy for treatment of women with axillary lymph node … Protect from light.Storage of the solution for injection at refrigerated conditions can result in the formation of a gelled product. 0000008202 00000 n HIGHLIGHTS OF PRESCRIBING INFORMATION . 0000009702 00000 n If you have further questions, please ask your doctor or pharmacist. endstream endobj startxref 0000012442 00000 n Epirubicin had no effect on the exposure of paclitaxel whether it was administered before or after paclitaxel. How Epirubicin Hydrochloride Injection is given to you 4. 4 0 obj 0000002031 00000 n <> 0000010198 00000 n DAUNORUBICIN HYDROCHLORIDE INJECTION Rx ONLY. !1]dwI�zyz��A��%B4������&'?.��n��V)ظ�kV�0徢����ź6'5�}`hErm��{`��9��'v�@���ۯU��/����V$�L��lL�'�Ő|�F>��$��b>q'�V�;u�w�$=�R����#0p�xRN�vb������`�b���0#�s��k� ��[�^R�m0.$��XB�e��]��O+s���&9U�Fz���6�p�K�e�Jl�d��eI�h�9H .Z�_)P�3zj����;�{�y��tSgo��4�$֮9�ZO%�!�u���ȡ���� ~��

%PDF-1.6 %���� 0000121000 00000 n trailer ��T�c�O)N�X#:8D�fq����g\B`B���gS���苻���Q��hf's@Mv�B�k 0000003762 00000 n 3 0 obj Joinly developed with the Society of Urologic Nurses and Associates (SUNA) I. For intravenous or intravesical use … 0000134485 00000 n %���� Epirubicin Hydrochloride Injection, USP is available in single-use vials containing 2 mg epirubicin hydrochloride, USP per mL as a sterile, preservative-free, ready-to-use solution in the following strengths:Store refrigerated between 2°C and 8°C (36°F and 46°F).